fbpx

Warren Buffett is Buying These 4 Pharmaceutical Stocks, Should You? By StockNews


© Reuters. Warren Buffett is Buying These 4 Pharmaceutical Stocks, Should You?

The pharmaceutical industry is undoubtedly playing a vital role in battling the COVID-19 pandemic. Many pharma companies are delivering huge gains thanks to the heightened demand for their COVID-19-related products. And because the pandemic is nowhere near defeated, Warren Buffett is betting on major pharma stocks Pfizer (PFE), AbbVie (ABBV), Merck & Co. (MRK), and Bristol-Myers (BMY). So, let’s find out if it’s worth emulating the legendary investor.Known as the “Oracle (NYSE:) of Omaha,” Warren Buffett is one of the most successful investors ever, Buffett’s Berkshire Hathaway (NYSE:) (BRK.A) recovered all of its pandemic-driven losses in the second quarter of 2021 to hit a record high. BRK.A’s operating income rose 21% year-over-year to $6.69 billion in the second quarter, while its equity investments rose 6.8% from the prior-year quarter to $28 billion. Shares of BRK.A have gained 36.4% over the past year and 25.5% year-to-date, outperforming the broader S&P 500 index’s 32.2% gains and 18.8% returns, respectively.

Buffett has a substantial stake in the pharmaceutical industry. He invested billions of dollars in big pharma stocks last year. The shares of pharma companies rallied powerfully last year on increased demand for therapeutic drugs, supplements, and other remedial needs for COVID-19. According to Statista, approximately $1.27 trillion was spent on medicines in 2020, up from just $887 billion in 2010.

As of September 2020, Berkshire Hathaway had invested $136 million in Pfizer Inc. (NYSE:) and more than $1.8 billion each in AbbVie Inc . (NYSE:), Merck & Co., Inc. (MRK), and Bristol-Myers Squibb Company (NYSE:). And the renowned investor’s long-term value investing strategy paid off because these stocks gained significantly. Considering their solid market position and sound financials, we think these four pharma stocks could still be worth buying.

Continue reading on StockNews

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.



Source link

Leave a Reply

Your email address will not be published.

^N225 
$27,819.33  $180.63  0.65%  
SGHIF 
$1.41  $0.0000  0.00%  
^HSIL 
$23.91  $1.63  6.38%  
SZNTF 
$0.2006  $0.0000  0.00%  
KOSPI.KS 
$2,523.78  $42.90  1.73%  
AUS.NZ 
$3.08  $0.012  0.39%  
^NSEI 
₹ 17,654.60  ₹ 119.85  0.68%  
FCNBCA.FGI 
$8,164.56  $175.85  2.20%  
EURUSD=X 
$1.03  $0.0032  0.31%  
GBPUSD=X 
$1.22  $0.0008  0.07%  
JPY=X 
$132.47  $0.406  0.31%  
^GSPC 
$4,210.24  $87.77  2.13%  
NDAQ 
$186.60  $3.43  1.87%  
^DJI 
$33,309.51  $535.11  1.63%